FDA Inspection 1215337 — Department of Defense - Navy (U.S. Naval Hospital Naples)

Department of Defense - Navy (U.S. Naval Hospital Naples) — FEI 3002809584

The FDA completed an inspection of Department of Defense - Navy (U.S. Naval Hospital Naples) on July 21, 2023 in Naples. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 21, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Naples (Italy)